Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
36 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsRoche announces CHMP recommendation for EU approval of Venclyxto plus MabThera for people with previously treated chronic lymphocytic leukaemia
(WorldNews Switzerland)

 
 

21 september 2018 17:30:08

 
Roche announces CHMP recommendation for EU approval of Venclyxto plus MabThera for people with previously treated chronic lymphocytic leukaemia
(WorldNews Switzerland)
 


Basel, 21 September 2018 Roche announces CHMP recommendation for EU approval of Venclyxto plus MabThera for people with previously treated chronic lymphocytic leukaemia Positive CHMP recommendation based on randomised phase III MURANO study showing that fixed duration of treatment with Venclyxto plus MabThera is well tolerated and reduced risk of disease progression or death by 83% compared to bendamustine plus MabThera Venclyxto in combination with MabThera represents a potential new chemotherapy-free option for treating people with previously treated chronic lymphocytic leukaemia Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the EU Committee for Medicinal Products for Human Use...


 
16 viewsCategory: General > Europe > Switzerland
 
HUMAN RIGHTS COUNCIL ADOPTS UNIVERSAL PERIODIC REVIEW OUTCOMES OF CANADA, CUBA AND THE RUSSIAN FEDERATION
(WorldNews Switzerland)
Transocean Ltd. Announces Six-Well Contract for Transocean Norge
(WorldNews Switzerland)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten